Primary prevention of hepatocellular carcinoma in developing countries.
about
Mycotoxins and human disease: a largely ignored global health issuePostweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa.Analysis of Risk Factors Associated with the Development of Hepatocellular Carcinoma in Chronic HBV-Infected Chinese: A Meta-AnalysisBiologically Based Methods for Control of Fumonisin-Producing Fusarium Species and Reduction of the FumonisinsThe global epidemiology of hepatocellular carcinoma: present and futurePartially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis.The global burden of cancer: priorities for prevention.Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation.Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventionsHepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Evaluating the technical feasibility of aflatoxin risk reduction strategies in AfricaGlobal burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.Prognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infectionsIdentification of maize genes associated with host plant resistance or susceptibility to Aspergillus flavus infection and aflatoxin accumulation.Prevalence of HCV among the high risk groups in Khyber PakhtunkhwaEfficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation programSeasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.Epidemiology of hepatitis C: related hepatocellular carcinoma in CameroonFrequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.Elm tree bark extract inhibits HepG2 hepatic cancer cell growth via pro-apoptotic activityIdentification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resectionRisk Assessment on Dietary Exposure to Aflatoxin B₁ in Post-Harvest Peanuts in the Yangtze River Ecological Region.Metformin inhibits early stage diethylnitrosamine‑induced hepatocarcinogenesis in rats.Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran.Disease monitoring of hepatocellular carcinoma through metabolomics.Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study.Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Liver cancer in low and middle income countries.A Histological Study of Aspergillus flavus Colonization of Wound Inoculated Maize Kernels of Resistant and Susceptible Maize Hybrids in the Field.
P2860
Q24650056-CA81B4FA-88FB-40BE-8D30-B539C1DB052AQ24815686-DCE3AE97-07A5-4281-8468-75B01C4AF836Q26744336-AFE7F5D9-39C9-41F2-AE45-9550DFDF98A4Q26747463-DA7E1D57-04CA-435C-B294-E5A332E332E7Q28654353-82ADCE39-1DA2-4D36-8DF0-714D6067A218Q28742762-992F6EED-84C0-4171-9CC3-4B80E99E575CQ31049390-ADFB88C8-4203-4C41-94B2-05D41395B174Q33575717-44B33B82-CBCD-40BE-9B6A-BEFBFFF6437CQ33647365-549BBF29-F92D-4B8E-BA55-AAB952BCB09CQ33785710-DE1989BD-BEF7-455C-AA4C-D5D7C0370B39Q33805854-BFA90B7B-55E6-4E77-BC16-0C5085A4A440Q33866448-10E9A34B-AB8C-4C3A-89E8-A65D2DF62EBCQ33901917-6754065D-C287-4626-AAF1-15DBE4FFB554Q33969253-2D8A2510-556E-49EC-9425-849B35DF86BCQ34061430-A25075CB-FFE7-439A-AA74-6B3AD330E373Q34093887-EE9F4499-A904-4F23-B869-CDA0E94F3FA2Q34273757-7491047C-A08F-459B-9E11-1C0E08229362Q35063992-79DEA1FE-C156-4287-8AF2-0451CD2596F2Q35084497-62FF204B-38BC-4BD3-BF71-F3CC39F8CA42Q35579913-4284F0C9-F621-4272-B06B-C6E43E95AD6AQ35593576-FFC9E4C9-7975-4EF9-9A93-931F1B5A4AC0Q35699313-A9B305D4-C94D-42AE-B65E-C068559CF116Q35865558-B754F8B9-E35B-4E44-9510-831460BBA767Q36226478-E3A8A5B6-7FE7-43E8-BE47-7E8C248AF3D1Q36226874-3E690AE6-AED3-4015-93A8-83566F67268FQ36390358-388D4AB4-FB7E-47ED-B3DF-F0A9B74C1A03Q36461735-283ACD70-CDF6-4464-A6D7-3508E85873E4Q36879898-6E611538-4B15-444A-85E5-37B9B62872BAQ38768256-EC0E00B3-4C02-435F-BE31-9E5B88616F6DQ39613595-06BB063C-3174-4264-B17A-523BF20C74C4Q39917877-CF90DF18-9125-441E-93C5-BFC29A3B6466Q41962614-8E1AB0D2-DFA3-447F-94D3-5F67E2BF8693Q42783116-E5EA4F18-C988-4057-BCC8-5749E4A455AFQ55273663-5426EFC2-FFD4-4B1D-A5B4-463E02D416F6
P2860
Primary prevention of hepatocellular carcinoma in developing countries.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Primary prevention of hepatocellular carcinoma in developing countries.
@ast
Primary prevention of hepatocellular carcinoma in developing countries.
@en
type
label
Primary prevention of hepatocellular carcinoma in developing countries.
@ast
Primary prevention of hepatocellular carcinoma in developing countries.
@en
prefLabel
Primary prevention of hepatocellular carcinoma in developing countries.
@ast
Primary prevention of hepatocellular carcinoma in developing countries.
@en
P1433
P1476
Primary prevention of hepatocellular carcinoma in developing countries
@en
P2093
P304
P356
10.1016/S1383-5742(00)00027-2
P407
P577
2000-04-01T00:00:00Z